NewtekOne, Inc. Form 8-K Summary
Business Context and Reporting Period
NewtekOne, Inc. (NEWT) filed a Current Report on Form 8-K dated September 30, 2025. The Company is incorporated in Maryland and maintains its principal executive offices in Boca Raton, Florida. The filing primarily serves to announce a corporate action regarding shareholder distributions.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data for the period. The only specific financial metric disclosed is the declaration of a quarterly dividend.
- Quarterly Dividend: $0.19 per share.
- Debt Instruments Registered: The Company has multiple notes and preferred stock registered on the Nasdaq Global Market, including 5.50% Notes due 2026, 8.00% Notes due 2028, 8.50% Notes due 2029, 8.625% Notes due 2029, and Depositary Shares for 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B.
Material Changes
The material change reported is the declaration of the quarterly dividend. The filing does not disclose material changes in revenue, operating results, or liquidity positions compared to prior periods.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements, noting that actual results may differ materially from expectations due to significant risks and uncertainties. Management does not undertake to update these statements. No specific operational guidance or outlook was provided in this report. The Company directs investors to its Risk Factors section in other SEC filings for detailed risk disclosures.
Investor Verification Checklist
- Verify the record date and payment date for the $0.19 per share dividend in the attached Press Release (Exhibit 99.1).
- Review the Company's most recent 10-Q or 10-K for detailed revenue, profit, and liquidity metrics, as this 8-K does not contain them.
- Confirm the status of the Company's registered debt securities (NEWTZ, NEWTI, NEWTG, NEWTH, NEWTP) for upcoming maturity or interest payment obligations.